Worldwide Pain Therapeutics 2021 Industry Report - Key
23 Jun 2021
Acquisition
Dublin, June 23, 2021 (GLOBE NEWSWIRE) -- The "Global Pain Therapeutics Market - Comprehensive Overview of Marketed and Pipeline Products, Opportunities, Challenges, Market Size and Key Players" report has been added to ResearchAndMarkets.com's offering. Pain is a multifaceted disorder that can be classified in a multitude of ways. Pain can be classified based on physiology, intensity, temporal characteristics, type of tissue affected, and syndrome.Innovation in the pain market over the last decade has been limited to new drug delivery systems, new extended-release formulations, and the repositioning of anticonvulsant and antidepressant therapeutics for difficult-to-treat pain conditions.Despite the improvements in symptom relief offered by new treatments and delivery systems, the pain market still has significant unmet needs. Opioids remain the most effective modes of treatment. However, because of their abuse potential, they are typically administered for chronic pain conditions.For the scope of this report, the publisher will use the time course classification, with the main focus on chronic pain.This report assesses:
The report combines information obtained from secondary sources and primary research with specialists and physicians.The publisher's Global Pain Therapeutics Market Overview report combines primary research from a cross-specialty panel of experts with in-house analyst expertise to provide an assessment of the development landscape.Key Highlights
ScopeComponents of the slide deck include primary and secondary research -
Reasons to Buy
Key Topics Covered: 1. Preface2. Executive Summary2.1. Key Findings3. Pain Overview4. Trends5. Clinical Trials5.1. Pain Therapeutics in Clinical Trials5.2. Pain Therapeutics Clinical Trials by Region5.3. Pain Therapeutics Clinical Trials by Leading Sponsors5.4. Pain Therapeutics in Clinical Trials - Challenges5.5. Pain Therapeutics in Clinical Trials - Opportunities6. Marketed Products6.1. Marketed Global Pain Products6.2. NSAIDs and COX-2 inhibitors6.3. Opioids6.4. Antidepressants and Anticonvulsants7. Pipeline Products7.1. Global Pain Therapeutics Pipeline Products7.2. Beta Nerve Growth Factor Target7.3. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Type I Receptor Target7.4. Neurotensin Receptor 1 Target8. Market Analysis8.1. Mixed Pain Market Analysis and Forecast8.2. Neuropathic Pain Market Analysis and Forecast8.3. Nociceptive Pain Market Analysis and Forecast8.4. Top 10 Deals in the Pain Therapeutics Space8.5. H1 2021 Deals in the Pain Therapeutics Space8.6. H2 2020- H1 2021 Mergers and Acquisitions in the Pain Therapeutics Space9. Opportunities, Challenges, and Unmet Needs9.1. Global Pain Therapeutics - Opportunities9.2. Global Pain Therapeutics - Challenges9.3. Global Pain Therapeutics Unmet Needs - Gap Analysis10. Key Players10.1. Pfizer10.2. Eli Lilly10.3. Allergan10.4. Teva10.5. Viatris10.6. Novartis11. Appendix11.1. Bibliography11.2. Primary Research11.3. About the Authors11.4. About the Publisher11.5. Contact the Publisher11.6. DisclaimerFor more information about this report visit
Organizations
Indications
Targets
Drugs
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.